174PD A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)

Tengyu Zhang, Jin‐Feng Zhu, J.y. Chen, Yongxue Zhu, Jie Zhou, Jinda Jia, Chao-Tuan Zhang, X. Wang, Yingchen Gao, Guozhen Cai, Bin Luo, Jiaye Wu, A. Liu, Bing Xu, Zhi-Yin ZhangAnnals 2016 · DOI

BibTeX
@article{zhang2016pd,
  author = {Tengyu Zhang and Jin‐Feng Zhu and J.Y. Chen and Yongxue Zhu and Jie Zhou and Yongxue Zhu and Jinda Jia and Chao-Tuan Zhang and X. Wang and Yingchen Gao and Guozhen Cai and Bin Luo and Jiaye Wu and A. Liu and Bing Xu and Zhi-Yin Zhang},
  title = {{174PD A randomized phase III trial of capecitabine with or without irinotecan driven by UGT1A1 in neoadjuvant chemoradiation of locally advanced rectal cancer (CinClare)}},
  journal = {Annals},
  year = {2016},
  doi = {10.1093/annonc/mdw581.006},
}

Loading related content...

Figure